BackMiNK Therapeutics Overview

MiNK Therapeutics Total Liabilities

MiNK Therapeutics's total liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$0.00

Peer average

Loading

MiNK Therapeutics Total Liabilities History

Loading

MiNK Therapeutics vs. peers: Total Liabilities Comparison

Loading

MiNK Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MiNK Therapeutics (INKT) FAQ

As of the most recent data (March 2026), INKT shows a total liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INKT's total liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether MiNK Therapeutics is outperforming or lagging.

Tracking INKT's total liabilities over time shows whether MiNK Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has MiNK Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $0) with ownership activity and broader fundamentals.

MiNK Therapeutics's total liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.